Novartis Investigative Site

Randwick, New South Wales 2031

We've found

1 trials

at this facility

Phase I Study of LDK378 in Pediatric, Malignancies With a Genetic Alteration in Anaplastic Lymphoma Kinase (ALK)

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Randwick,

Use our guide to learn which trials are right for you!